Abstract
OBJECTIVE: To test the hemodynamic efficacy and feasibility of nitric oxide (NO) administration by oxygen hood in neonatal pulmonary hypertension.
STUDY DESIGN: A double-hood apparatus was used in which a combination of NO, O2, and N2 was introduced into the inner hood and suctioned from the outer hood. Chronically instrumented non-intubated piglets were exposed to 10% O2 (hypoxia; n=8) or group B streptococci infusion (GBS; n=5) to produce pulmonary hypertension and were then exposed to 20 ppm NO.
RESULTS: NO decreased (>50%) pulmonary artery pressure and vascular resistance in both hypoxia- and GBS-induced pulmonary hypertension, with minimal effects on systemic arterial pressure and cardiac output. NO administration could be performed without detectable environmental leakage.
CONCLUSION: Hood NO administration is feasible and shows hemodynamic efficacy in neonatal piglets with pulmonary hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Walsh-Sukys MC . Persistent pulmonary hypertension of the newborn. The black box revisited Clin Perinatol 1993 20: 127–43
The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure N Engl J Med 1997 336: 597–604
Kinsella JP, Truog WE, Walsh WF . Randomized multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn J Pediatr 1997 131: 55–62
Rosenberg AA, Kennaugh JM, Moreland SG . Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension J Pediatr 1997 131: 70–5
Wessel DL, Adatia I, Van Marter LJ . Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn Pediatrics 1997 100: e7 http://www.pediatrics.org/cgi/content/full/100/5/e7
Roberts JD, Fineman JR, Morin FC III . Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group N Engl J Med 1997 336: 605–10
Davidson D, Barefield ES, Kattwinkel J . Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose–response, multicenter study Pediatrics 1998 101: 325–34
Truog WE . Inhaled nitric oxide: a tenth anniversary observation Pediatrics 1998 101: 696–7
Bancalari E, Gerhardt T . Bronchopulmonary dysplasia Pediatr Clin North Am 1986 33: 1–23
Mariani GL, Carlo WA . Ventilatory management in neonates. Science or art? Clin Perinatol 1998 25: 33–48
Philips JB, Li JX, Gray BM . Role of capsule in pulmonary hypertension induced by group B streptococcus Pediatr Res 1992 31: 386–90
Nitric Oxide Delivery System, PPHN Clinical Study Manual Madison, WI: BOC Health Care. Ohmeda 1994
INOVent Delivery System for Inhaled Nitric Oxide Operation and Maintenance Manual Madison, WI: Ohmeda. Ohmeda 1997
National Institute for Occupational Safety and Health. IDLH documentation for nitric oxide ( http://siri.uvm.edu/nioshdb/idlh/10102439.htm ) and nitrogen dioxide ( http://siri.uvm.edu/nioshdb/idlh/10102440.htm )
Steinhorn RH, Millard SL, Morin FC III . Persistent pulmonary hypertension of the newborn. Role of nitric oxide and endothelin in pathophysiology and treatment Clin Perinatol 1995 22: 405–28
Tarpey MN, Graybar GB, Lyrene RK . Thromboxane synthesis inhibition reverses group B Streptococcus-induced pulmonary hypertension Crit Care Med 1987 15: 644–7
Kakuya F, Takase M, Ishii N . Inhaled nitric oxide therapy via nasopharyngeal tube in an infant with end-stage pulmonary hypertension Acta Paediatr Jpn 1998 40: 155–8
Carlo WA, Martin RJ, Bruce EN . Alae nasi activation (nasal flaring) decreases nasal resistance in preterm infants Pediatrics 1983 72: 338–43
Solow B, Pietersen B . Nasal airway resistance in the newborn Rhinology 1991 29: 27–33
Ivy DD, Griebel JL, Kinsella JP . Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension J Pediatr 1998 133: 453–6
Aly H, Sahni R, Wung JT . Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn Arch Dis Child Fetal–Neonat Ed 1997 76: F118–22
Francoise M, Gouyon JB, Mercier JC . Hemodynamics and oxygenation changes induced by the discontinuation of low-dose inhalational nitric oxide in newborn infants Intensive Care Med 1996 22: 477–81
Finer NN, Etches PC, Kamstra B . Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response J Pediatr 1994 124: 302–8
Acknowledgements
We acknowledge the assistance of Tom Gadilhe RRT for his technical assistance in this project.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ambalavanan, N., St. John, E., Carlo, W. et al. Feasibility of Nitric Oxide Administration by Oxygen Hood in Neonatal Pulmonary Hypertension. J Perinatol 22, 50–56 (2002). https://doi.org/10.1038/sj.jp.7210652
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210652
This article is cited by
-
Protective effect of platinum nano-antioxidant and nitric oxide against hepatic ischemia-reperfusion injury
Nature Communications (2022)